Although there is a potential mechanistic link in the activity of pyrimidine pathway and differentiation blockade in AML patients, our analysis of the expression of DHODH and UMPS further suggests that patients who could potentially benefit from the modulation of the activity of pyrimidine synthesis pathway are not easily identifiable using conventional diagnostic markers in AML. Here, DHODH is linked to acute myeloid leukemia.